Cleared Traditional

K082065 - WELL LIFE SELF ADHESIVE ELECTRODE / MODELS: CM, FA, PU AND SP

K082065 is an FDA 510(k) clearance for WELL LIFE SELF ADHESIVE ELECTRODE / MOD..., manufactured by Well-Life Healthcare Limited. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 262-day FDA review.

K082065 · Well-Life Healthcare Limited · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
262d
Days
Class 2
Risk

K082065 is an FDA 510(k) clearance for the WELL LIFE SELF ADHESIVE ELECTRODE / MODELS: CM, FA, PU AND SP. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Well-Life Healthcare Limited (Bonita Springs, US). The FDA issued a Cleared decision on April 10, 2009 after a review of 262 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Well-Life Healthcare Limited devices

FDA 510(k) Submission Details - K082065

510(k) Number K082065 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2008
Decision Date April 10, 2009
Days to Decision 262 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
114d slower than avg
Panel avg: 148d · This submission: 262d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 238
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K082065.
BIS QUATRO SENSOR
K093183 · Aspect Medical Systems, Inc. · Oct 2009
LIFECARE ELECTRODES
K083302 · Everyway Medical Instruments Co.,Ltd · Aug 2009
BIS CLICK SENSOR/CABLE
K091854 · Aspect Medical Systems, Inc. · Jul 2009
UNIVERSAL ELECTRODES
K083818 · Neurometrix, Inc. · Jan 2009
GE ENTROPY SENSOR
K082540 · Ge Healthcare · Nov 2008
UNIVERSAL ELECTRODES
K081871 · Neurometrix, Inc. · Sep 2008